Akèy › Atrit psoryatik
Etid klinik pou Atrit psoryatik ap rekrite nan Etazini
30 etid pou Atrit psoryatik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX8 etid
- Charlotte, NC7 etid
- Philadelphia, PA6 etid
- Parma, OH6 etid
- Tampa, FL6 etid
- Altoona, PA6 etid
- San Diego, CA5 etid
- New York City, NY5 etid
- Cleveland, OH5 etid
- Milwaukee, WI5 etid
- Clearwater, FL5 etid
- Plantation, FL5 etid
- Seattle, WA4 etid
- Durham, NC4 etid
- Phoenix, AZ4 etid
- Kansas City, MO4 etid
- Dallas, TX4 etid
- Orlando, FL4 etid
- Hialeah, FL4 etid
- Albuquerque, NM4 etid
- Jackson, TN4 etid
- Thousand Oaks, CA4 etid
- Huntington Beach, CA4 etid
- Baytown, TX4 etid
- Tucson, AZ4 etid
- Arlington, TX4 etid
- Baltimore, MD4 etid
- The Woodlands, TX4 etid
- Columbus, OH3 etid
- Indianapolis, IN3 etid
- Cincinnati, OH3 etid
- Salt Lake City, UT3 etid
- Washington, DC3 etid
- Portland, OR3 etid
- Boston, MA3 etid
- St. Louis, MO3 etid
- Hagerstown, MD3 etid
- Mesquite, TX3 etid
- Hollywood, FL3 etid
- Lansing, MI3 etid
Pa eta
- Arizona8 etid
- Arkansas4 etid
- Colorado4 etid
- Connecticut3 etid
- Distrik Columbia3 etid
- Florid14 etid
- Georgia7 etid
- Illinois6 etid
- Indiana4 etid
- Kalifòni13 etid
- Kentucky3 etid
- Maryland7 etid
- Massachusetts4 etid
- Michigan4 etid
- Missouri5 etid
- New Jersey3 etid
- New Mexico4 etid
- New York8 etid
- North Carolina11 etid
- Ohio14 etid
- Oregon3 etid
- Pennsylvania12 etid
- South Carolina3 etid
- Tennessee7 etid
- Texas17 etid
- Utah3 etid
- Washington6 etid
- Wisconsin5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Ap rekriteFaz 3
Laj 3 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06663332A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07321873A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06807424A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Sep 25, 2026 · NCT07801495Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Ap rekriteFaz 1
Laj 18 ak plis · Fanm · Mizajou Sep 18, 2026 · NCT06888193A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 14, 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06641089Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07286058A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06671496A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Ap rekriteFaz 3
Laj 5 a 17 · Tout sèks · Mizajou Sep 1, 2026 · NCT06100744Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT07280702A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Aug 28, 2026 · NCT07654751Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Ap rekriteEtid obsèvasyon
Jiska laj 21 · Tout sèks · Mizajou Aug 27, 2026 · NCT02418442Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Ap rekrite
Laj 18 a 100 · Tout sèks · Mizajou Aug 10, 2026 · NCT07180537Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT07111494Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT07138898A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT07290036Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
Ap rekrite
Tout laj · Tout sèks · Mizajou Jun 10, 2026 · NCT06586281Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT04751396A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Apr 3, 2026 · NCT06454188Rheumatology Patient Registry and Biorepository
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Feb 13, 2026 · NCT04402086Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 ak plis · Tout sèks · Mizajou Jan 22, 2026 · NCT04806620Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT06865105Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.